Anandron (RU 23908) in metastatic prostate cancer: preliminary results of a multicentric Italian study. [electronic resource]
- Cancer detection and prevention 1991
- 501-3 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study
0361-090X
Aged Aged, 80 and over Androgen Antagonists--adverse effects Antineoplastic Agents--adverse effects Humans Imidazoles--adverse effects Imidazolidines Male Middle Aged Neoplasm Staging Prostatic Neoplasms--drug therapy Vision Disorders--chemically induced